HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Gerresheimer Buys Plastic Vials Maker Centor

By HospiMedica International staff writers
Posted on 23 Aug 2015
Print article
Image: The Centor 1-Clic vial (Photo courtesy of Centor).
Image: The Centor 1-Clic vial (Photo courtesy of Centor).
Advanced healthcare glass and plastic products manufacturer Gerresheimer (Düsseldorf, Germany) has agreed to purchase plastic vial maker Centor (Perrysburg, OH, USA) for USD 725 million in cash.

Gerresheimer is a leading global partner to the pharmacetical and healthcare industries specializing in glass and plastic products. The comprehensive product portfolio includes safe drug-delivery systems such as insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, as well as cosmetic packaging products. The deal is designed to extend Gerresheimer’s footprint by leveraging Centor’s position as the leading manufacturer of plastic vials and closures for oral drugs in the United States.

Centor, which will be integrated in the plastics and devices division of Gerresheimer, manufactures the Screw-Loc child resistant package, an industry standard for over 40 years, and the 1-Clic vial for dispensed medications, which opens easily with minimal tab pressure and a slight turn, emitting an audible "click" to ensure it is properly secured. The US prescription industry is structured around the “pour-and-count” system, whereby the exact number of prescribed oral drugs is delivered in secure plastic vials.

“Centor is the highly profitable market leader for plastic vials and closures in the prescription retail market,” said Uwe Röhrhoff, CEO of Gerresheimer. “This is a perfect fit to extend our product offering from packaging of parenterals to the packaging of oral drugs in the United States. We expect that this acquisition will increase shareholder value significantly.”

“We are happy to join the Gerresheimer Group with its high expertise in primary pharmaceutical packaging,” said Paul Arsenault, president of Centor. “In the future we will contribute to Gerresheimer’s success with our market leadership in the North American prescription plastic vial retail market.”

Related Links:

Gerresheimer
Centor


Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Video Laryngoscope
SH-VL1

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more